dimosieuseis1: Cordeiro ER, Anastasiadis A, Bus MT, Alivizatos G, de la Rosette JJ, de Reijke TM. Is photodynamic diagnosis ready for introduction in urological clinical practice? Expert Rev Anticancer Ther. 2013 Jun;13(6):669-80. doi: 10.1586/era.13.60. PubMed PMID: 23773102.

2: Mamoulakis C, Skolarikos A, Schulze M, Scoffone CM, Rassweiler JJ, Alivizatos G, Scarpa RM, de la Rosette JJ. Bipolar vs monopolar transurethral resection of the prostate: evaluation of the impact on overall sexual function in an international randomized controlled trial setting. BJU Int. 2013 Jul;112(1):109-20. doi: 10.1111/j.1464-410X.2012.11662.x. Epub 2013 Mar 12. PubMed PMID: 23490008.

3: Ploumidis A, Skolarikos A, Sopilidis O, Chalikopoulos D, Alivizatos G, Wiklund P. Sequential robotic-assisted bladder diverticulectomy and radical prostatectomy. Technique and review of the literature. Int J Surg Case Rep. 2013;4(1):81-4. doi: 10.1016/j.ijscr.2012.10.002. Epub 2012 Oct 8. PubMed PMID: 23123421; PubMed Central PMCID: PMC3537925.

4: Mamoulakis C, Schulze M, Skolarikos A, Alivizatos G, Scarpa RM, Rassweiler JJ, de la Rosette JJ, Scoffone CM. Midterm results from an international multicentre randomised controlled trial comparing bipolar with monopolar transurethral resection of the prostate. Eur Urol. 2013 Apr;63(4):667-76. doi: 10.1016/j.eururo.2012.10.003. Epub 2012 Oct 12. PubMed PMID: 23102675.

5: Anastasiadis A, Cordeiro E, Bus MT, Alivizatos G, de la Rosette JJ, de Reijke TM. Follow-up procedures for non-muscle-invasive bladder cancer: an update. Expert Rev Anticancer Ther. 2012 Sep;12(9):1229-41. doi: 10.1586/era.12.98. Review. PubMed PMID: 23098122.

6: Spyridopoulos TN, Dessypris N, Antoniadis AG, Gialamas S, Antonopoulos CN, Katsifoti K, Adami HO, Chrousos GP, Petridou ET; Obesity and Cancer Oncology Group. Insulin resistance and risk of renal cell cancer: a case-control study. Hormones (Athens). 2012 Jul-Sep;11(3):308-15. PubMed PMID: 22908063.

7: Mamoulakis C, Skolarikos A, Schulze M, Scoffone CM, Rassweiler JJ, Alivizatos G, Scarpa RM, de la Rosette JJ. Results from an international multicentre double-blind randomized controlled trial on the perioperative efficacy and safety of bipolar vs monopolar transurethral resection of the prostate. BJU Int. 2012 Jan;109(2):240-8. doi: 10.1111/j.1464-410X.2011.10222.x. Epub 2011 May 9. PubMed PMID: 21557796.

8: Antoniewicz AA, Alivizatos G, Zapała Ł, de Reijke TM. GreenLight™ laser in the treatment of lower urinary tract symptoms due to benign prostatic enlargement. Expert Rev Med Devices. 2011 Mar;8(2):139-47. doi: 10.1586/erd.10.91. PubMed PMID: 21381906.

9: Skolarikos A, Laguna MP, Alivizatos G, Kural AR, de la Rosette JJ. The role for active monitoring in urinary stones: a systematic review. J Endourol. 2010 Jun;24(6):923-30. doi: 10.1089/end.2009.0670. Review. PubMed PMID: 20482232.

10: Bamias A, Aravantinos G, Kastriotis I, Alivizatos G, Anastasiou I, Christodoulou C, Gyftaki R, Kalofonos HP, Dimopoulos MA. Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): a risk adapted protocol of the Hellenic Cooperative Oncology Group. UrolOncol. 2011 Mar-Apr;29(2):189-93. doi: 10.1016/j.urolonc.2009.01.017. Epub 2009 Apr 11. PubMed PMID: 19362863.

11: Chatzidarellis EP, Skolarikos A, Mazaris E, Mitsogiannis I, Alivizatos G. Postradical cystectomy bowel perforation caused by a drainage tube: a case report. Cases J. 2008 Nov 25;1(1):350. doi: 10.1186/1757-1626-1-350. PubMed PMID: 19032750; PubMed Central PMCID: PMC2605765.

12: Skolarikos A, Papachristou C, Athanasiadis G, Chalikopoulos D, Deliveliotis C, Alivizatos G. Eighteen-month results of a randomized prospective study comparing transurethral photoselective vaporization with transvesical open enucleation for prostatic adenomas greater than 80 cc. J Endourol. 2008 Oct;22(10):2333-40. doi: 10.1089/end.2008.9709. PubMed PMID: 18837655.

13: Alivizatos G, Skolarikos A. Photoselective vaporization of the prostate to manage benign prostatic hyperplasia. J Endourol. 2008 Sep;22(9):2117-9. doi: 10.1089/end.2008.9731. PubMed PMID: 18811563.

14: Alivizatos G, Skolarikos A. Should holmium laser enucleation be the new gold standard for bladder outlet obstruction caused by BPH? Nat ClinPract Urol. 2008 Jul;5(7):358-9. doi: 10.1038/ncpuro1129. Epub 2008 May 20. PubMed PMID: 18490936.

15: Bamias A, Lainakis G, Kastritis E, Antoniou N, Alivizatos G, Koureas A, Chrisofos M, Skolarikos A, Karayiotis E, Dimopoulos MA. Biweekly carboplatin/gemcitabine in patients with advanced urothelial cancer who are unfit forcisplatin-based chemotherapy: report of efficacy, quality of life and geriatric assessment. Oncology. 2007;73(5-6):290-7. doi: 10.1159/000132394. Epub 2008 May 14. PubMed PMID: 18477854.

16: Alivizatos G, Skolarikos A. Greenlight laser in benign prostatic hyperplasia: turning green into gold. CurrOpin Urol. 2008 Jan;18(1):46-9. Review. PubMed PMID: 18090489.

17: Alivizatos G, Skolarikos A, Chalikopoulos D, Papachristou C, Sopilidis O, Dellis A, Kastriotis I, Deliveliotis C. Transurethral photoselective vaporization versustransvesical open enucleation for prostatic adenomas >80ml: 12-mo results of a randomized prospective study. Eur Urol. 2008 Aug;54(2):427-37. Epub 2007 Nov 29. PubMed PMID: 18069117.

18: Livadas KE, Varkarakis IM, Skolarikos A, Karagiotis E, Alivizatos G, Sofras F, Deliveliotis C, Bissas A. Ureteroscopic removal of mildly migrated stents using local anesthesia only. J Urol. 2007 Nov;178(5):1998-2001. Epub 2007 Sep 17. PubMed PMID: 17869304.

19: Bamias A, Bozas G, Antoniou N, Poulias I, Katsifotis H, Skolarikos A, Mitropoulos D, Alamanis C, Alivizatos G, Deliveliotis H, Dimopoulos MA. Prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience. Eur Urol. 2008 Feb;53(2):323-31. Epub 2007 Apr 5. PubMed PMID: 17445976.

20: Skolarikos A, Alivizatos G, Laguna P, de la Rosette J. A review on follow-up strategies for renal cell carcinoma after nephrectomy. Eur Urol. 2007 Jun;51(6):1490-500; discussion 1501. Epub 2007 Jan 9. Review. PubMed PMID: 17229521.

21: Ferakis N, Skolarikos A, Staios D, Liakouras C, Alivizatos G. Treatment characteristics and inherent prostatic features do not predict patient outcome after high-energy transurethral thermotherapy: a prospective study of prostalund feedback treatment. J Endourol. 2006 Dec;20(12):1075-81. PubMed PMID: 17206906.

22: Skolarikos A, Alivizatos G, Papatsoris A, Constantinides K, Zerbas A, Deliveliotis C. Ultrasound-guided percutaneous nephrostomy performed by urologists: 10-year experience. Urology. 2006 Sep;68(3):495-9. Epub 2006 Sep 18. PubMed PMID: 16979707.

23: Skolarikos AA, Papatsoris AG, Alivizatos G, Deliveliotis C. Molecular pathogenetics of renal cancer. Am J Nephrol. 2006;26(3):218-31. Epub 2006 May 29. Review. PubMed PMID: 16733347.

24: de la Rosette J, Alivizatos G. Lasers for the treatment of bladder outlet obstruction: are they challenging conventional treatment modalities? Eur Urol. 2006 Sep;50(3):418-20. Epub 2006 May 2. PubMed PMID: 16687204.

25: Skolarikos A, Alivizatos G, de la Rosette J. Extracorporeal shock wave lithotripsy 25 years later: complications and their prevention. Eur Urol. 2006 Nov;50(5):981-90; discussion 990. Epub 2006 Feb 7. Review. PubMed PMID: 16481097.

26: Alivizatos G, Skolarikos A. Is there still a role for open surgery in the management of renal stones? CurrOpin Urol. 2006 Mar;16(2):106-11. Review. PubMed PMID: 16479213.

27: Alivizatos G, Skolarikos A. Incontinence and erectile dysfunction following radical prostatectomy: a review. ScientificWorldJournal. 2005 Sep 13;5:747-58. Review. PubMed PMID: 16170437.

28: Kauer PC, Laguna MP, Alivizatos G, Joyce A, Muschter R, Swartz R, Tolley D, de la Rosette JJ; ESUT. Present practice and treatment strategies in endourological stone management: results of a survey of the European Society of Uro-technology (ESUT). Eur Urol. 2005 Aug;48(2):182-8. Epub 2005 Jan 19. PubMed PMID: 16005372.

29: Skolarikos A, Alivizatos G, Bamias A, Mitropoulos D, Ferakis N, Deliveliotis C, Dimopoulos MA. Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis? Int J Urol. 2005 Jun;12(6):563-9. PubMed PMID: 15985079.

30: Alivizatos G, Ferakis N, Mitropoulos D, Skolarikos A, Livadas K, Kastriotis I. Feedback microwave thermotherapy with the ProstaLund Compact Device for obstructive benign prostatic hyperplasia: 12-month response rates and complications. J Endourol. 2005 Jan-Feb;19(1):72-8. PubMed PMID: 15735388.

31: Alivizatos G, Skolarikos A, Albanis S, Ferakis N, Mitropoulos D. Unreliable residual volume measurement after increased water load diuresis. Int J Urol. 2004 Dec;11(12):1078-81. PubMed PMID: 15663678.

32: Alivizatos G, Skolarikos A, Sopilidis O, Ferakis N, Chorti M. Splenogonadal fusion: report of a case and review of the literature. Int J Urol. 2005 Jan;12(1):90-2. Review. PubMed PMID: 15661059.

33: Skolarikos A, Alivizatos G, de la Rosette JJ. Percutaneous nephrolithotomy and its legacy. Eur Urol. 2005 Jan;47(1):22-8. Review. PubMed PMID: 15582245.

34: Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol. 2004 Nov;46(5):547-54. PubMed PMID: 15474261.

35: Sofras F, Livadas K, Alivizatos G, DeliveliotisCh, Albanis S, Melekos M, Christoforidis K. Retrograde acuciseendopyelotomy: is it worth its cost? J Endourol. 2004 Jun;18(5):466-8. PubMed PMID: 15253822.

36: Laguna MP, Alivizatos G, De La Rosette JJ. Interstitial laser coagulation treatment of benign prostatic hyperplasia: is it to be recommended? J Endourol. 2003 Oct;17(8):595-600. Review. PubMed PMID: 14622478.

37: Alivizatos G, Skolarikos A, Laguna P. Recent data upon impotence, incontinence and quality of life issues concerning radical prostatectomy. Arch Esp Urol. 2003 Apr;56(3):321-30. Review. PubMed PMID: 12768997.

38: Karayiannis A, Varkarakis I, Chort M, Alivizatos G, Fragiskos S. Multifocality of renal cell tumors is a factor to consider before performing a partial nephrectomy. Anticancer Res. 2002 Sep-Oct;22(5):3103-7. PubMed PMID: 12530051.

39: Doumas K, Alivizatos G. Complications of laparoscopic urological surgery. Arch Esp Urol. 2002 Jul-Aug;55(6):730-6. Review. PubMed PMID: 12224171.

40: de la Rosette JJ, Alivizatos G, Laguna MP. Transurethral hot water balloon thermoablation. CurrUrol Rep. 2001 Aug;2(4):302-5. Review. PubMed PMID: 12084256.

41: Floratos DL, Sonke GS, Rapidou CA, Alivizatos GJ, Deliveliotis C, Constantinides CA, Theodorou C. Biofeedback vs verbal feedback as learning tools for pelvic muscle exercises in the early management of urinary incontinence after radical prostatectomy. BJU Int. 2002 May;89(7):714-9. PubMed PMID: 11966630.

42: de la Rosette JJ, Alivizatos G, Madersbacher S, Perachino M, Thomas D, Desgrandchamps F, de Wildt M; European Association of Urology. EAU Guidelines on benign prostatic hyperplasia (BPH). Eur Urol. 2001 Sep;40(3):256-63; discussion 264. PubMed PMID: 11684840.

43: Giannakopoulos S, Alivizatos G, Deliveliotis C, Skolarikos A, Kastriotis J, Sofras F. Encrusted cystitis and pyelitis. Eur Urol. 2001 Apr;39(4):446-8. PubMed PMID: 11306884.

44: Floratos DL, Alivizatos GJ, Debruyne FM, de la Rosette JJ. Transurethral microwave thermotherapy in the armamentarium of therapeutic modalities for benign prostatic hyperplasia. Tech Urol. 2000 Dec;6(4):256-61. Review. PubMed PMID: 11108561.

45: Laguna P, Alivizatos G. Prostate specific antigen and benign prostatic hyperplasia. CurrOpin Urol. 2000 Jan;10(1):3-8. Review. PubMed PMID: 10650506.

46: Deliveliotis C, Sofras F, Alivizatos G, Cristofis J, Nazlidou E, Katabekiou A. The effect of ESWL of renal calculi on pancreatic function. IntUrolNephrol. 1998;30(6):665-70. PubMed PMID: 10195857.

47: Giannakopoulos S, Gekas A, Alivizatos G, Sofras F, Becopoulos T, Dimopoulos C. Efficacy of escalating doses of intravesical interferon alpha-2b in reducing recurrence rate and progression in superficial transitional cell carcinoma. Br J Urol. 1998 Dec;82(6):829-34. PubMed PMID: 9883220.

48: Dimopoulos MA, Panopoulos C, Bamia C, Deliveliotis C, Alivizatos G, Pantazopoulos D, Constantinidis C, Kostakopoulos A, Kastriotis I, Zervas A, Aravantinos G, Dimopoulos C. Oral estramustine and oral etoposide for hormone-refractory prostate cancer. Urology. 1997 Nov;50(5):754-8. PubMed PMID: 9372887.

49: Alivizatos G, Deliveliotis C, Mitropoulos D, Raptides G, Louras G, Karayiannis A, Becopoulos T, Dimopoulos AM. Does free to total ratio of prostate-specific antigen alter decision-making on prostatic biopsy? Urology. 1996 Dec;48(6A Suppl):71-5. PubMed PMID: 8973704.

50: Deliveliotis C, Giannakopoulos S, Louras G, Koutsokalis G, Alivizatos G, Kostakopoulos A. Double-pigtail stents for distal ureteral calculi: an alternative form of definitive treatment. UrolInt. 1996;57(4):224-6. PubMed PMID: 8961491.

51: Deliveliotis C, Alivizatos G, Karayiannis A, Kontothanasis D, Makrychoritis K, Lysiotis P, Dimopoulos MA. The value of prostatic specific antigen in the early diagnosis of prostatic cancer: a Greek view. Br J Urol. 1995 May;75(5):637-41. PubMed PMID: 7542133.

52: de la Rosette JJ, de Wildt MJ, Alivizatos G, Froeling FM, Debruyne FM. Transurethral microwave thermotherapy (TUMT) in benign prostatic hyperplasia: placebo versus TUMT. Urology. 1994 Jul;44(1):58-63. PubMed PMID: 7518982.

53: Deliveliotis C, Alivizatos G, Stavropoulos NJ, Makrychoritis K, Koutsokalis G, Kiriakakis Z, Kostakopoulos A, Dimopoulos C. Influence of digital examination, cystoscopy, transrectal ultrasonography and needle biopsy on the concentration of prostate-specific antigen. Urol Int. 1994;53(4):186-90. PubMed PMID: 7531895.

54: de la Rosette JJ, Froeling FM, Alivizatos G, Debruyne FM. Laser ablation of the prostate: experience with an ultrasound guided technique and a procedure under direct vision. Eur Urol. 1994;25(1):19-24. PubMed PMID: 7508395.

55: Alivizatos G, Oosterhof GO. Update of hormonal treatment in cancer of the prostate. Anticancer Drugs. 1993 Jun;4(3):301-9. Review. PubMed PMID: 8358057.

56: Constantinides C, Alivizatos G, Mitropoulos D, Dimopoulos C. Regression of lymphadenopathy in patient with prostatic carcinoma after hormonal manipulation. Br J Urol. 1992 Aug;70(2):203-4. PubMed PMID: 1393446.

57: Alivizatos G, Dimopoulos A, Mitropoulos D, Alevizou K, Bougas D, Pantazopoulos D. Efficacy of eight serially measured markers for diagnosis of prostatic carcinoma. Arch Esp Urol. 1992 Apr;45(3):269-72. PubMed PMID: 1384439.

58: Alivizatos G, Pavlaki K, Giannopoulos A, Mitropoulos D, Tsega A, Deliveliotis C, Dimopoulos C. Nucleolar organizer regions in prostatic adenocarcinomas. Comparison with flow cytometric analysis, tumor grade, stage and serum prostate-specific antigen levels. Eur Urol. 1992;21(2):141-5. PubMed PMID: 1379922.

59: Pavlakis K, Alivizatos G, Mitropoulos D, Constantinides C, Skopelitou A, Kittas C, Dimopoulos C. Silver-binding nucleolar organizer regions in benign and malignant prostatic lesions. Urol Int. 1992;49(3):137-40. PubMed PMID: 1281586.

60: Giannopoulos A, Alivizatos G, Kyriakou V, Mitropoulos D, Dimopoulos MA. Carcinosarcoma of the bladder. Br J Urol. 1991 Jan;67(1):106-7. PubMed PMID: 1993267.

61: Alivizatos G, Dimopoulou I, Mitropoulos D, Dimopoulos AM, Koufakis I, Lykourinas M. Bladder cancer in a young girl with systemic lupus erythematosus treated with cyclophosphamide. ActaUrol Belg. 1991;59(1):133-7. PubMed PMID: 1927758.

62: Likourinas M, Conidaris D, Alivizatos G, Dimopoulos MA. Complete testicular feminisation syndrome in three sisters. Br J Urol. 1990 Mar;65(3):298-9. PubMed PMID: 2337751.

63: Giannopoulos A, Mitropoulos D, Davaris P, Alivizatos G, Dimopoulos MA. Squamous cell carcinoma of the renal pelvis presenting with a loin sinus. Eur Urol. 1989;16(6):466-8. PubMed PMID: 2591432.



logo hygeiaΝοσοκομείο ΥΓΕΙΑ: 
γραμματεύς η κ. Φιλίππου Μαρία, 
τηλ: 210-6867494, 6944331052

γραμματεύς η κ. Κακοσαίου Μίνα, 
τηλ:210-7214494, 6974958425 

Αλιβιζάτος Γεράσιμος: 
6932207085, gali@hol.gr

Copyright © 2024 Γεράσιμος Αλιβιζάτος MD, PhD, FEBU . Με την επιφύλαξη παντός δικαιώματος.
Created by Yes Positive Communication / Powered by Infinity